Technology area: Biotechnology & Pharmaceuticals
5 pending office actions • 3 art units • 3 examiners • 0 of 5 (0%) have an AI response strategy ready
BLUEALLELE CORPORATION maintains a portfolio focused on Biotechnology & Pharmaceuticals, currently facing 4 pending office actions. These matters are distributed among 2 distinct examiners and 2 distinct art units, suggesting a concentration of technical subject matter. The workload is notably concentrated, as SINGH, ANOOP KUMAR is the busiest examiner with 3 pending office actions under their review. This concentration allows the company to focus its primary prosecution efforts on a single individual's examination style.
With 4 pending office actions in total, the 3 cases assigned to SINGH, ANOOP KUMAR represent a significant portion of the company's active prosecution. The remaining cases are handled by the other of the 2 distinct examiners. This level of examiner concentration within 2 distinct art units implies that the company's biotechnology filings are likely closely related. For the practitioner, the relationship with SINGH, ANOOP KUMAR is a primary factor in the company's current USPTO trajectory.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (40%) |
| Multi-statute (no §101) | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SINGH, ANOOP KUMAR | 3 | 43.2% | +67.7% |
| LEITH, NANCY J | 1 | 74.7% | +44.0% |
| TRAN, CHRISTINA L | 1 | 51.6% | +49.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18947288 | MATERIALS AND METHODS FOR REDOSING SUBJECTS RECEIVING GENE INSERTION THERAPEUTICS | LEITH, NANCY J | — |
| 18526772 | METHODS FOR TARGETED INSERTION OF DNA IN GENES | SINGH, ANOOP KUMAR | — |
| 18526794 | METHODS FOR TARGETED INSERTION OF DNA IN GENES | SINGH, ANOOP KUMAR | — |
| 18526826 | METHODS FOR TARGETED INSERTION OF DNA IN GENES | SINGH, ANOOP KUMAR | — |
| 17802678 | METHODS FOR TREATING GAIN-OF-FUNCTION DISORDERS COMBINING GENE EDITING AND GENE THERAPY | TRAN, CHRISTINA L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18947288 | MATERIALS AND METHODS FOR REDOSING SUBJECTS RECEIVING GENE INSERTION THERAPEUTICS | LEITH, NANCY J | — |
| 18526772 | METHODS FOR TARGETED INSERTION OF DNA IN GENES | SINGH, ANOOP KUMAR | — |
| 18526794 | METHODS FOR TARGETED INSERTION OF DNA IN GENES | SINGH, ANOOP KUMAR | — |
| 18526826 | METHODS FOR TARGETED INSERTION OF DNA IN GENES | SINGH, ANOOP KUMAR | — |
| 17802678 | METHODS FOR TREATING GAIN-OF-FUNCTION DISORDERS COMBINING GENE EDITING AND GENE THERAPY | TRAN, CHRISTINA L | — |
| Art Unit | Apps |
|---|---|
| 1632 | 3 |
| 1636 | 1 |
| 1637 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18947288 | MATERIALS AND METHODS FOR REDOSING SUBJECTS RECEIVING GENE INSERTION THERAPEUTICS | LEITH, NANCY J | 1636 | §103§112 | Non-Final OA | — | Pending | Nov 14, 2024 |
| 18526772 | METHODS FOR TARGETED INSERTION OF DNA IN GENES | SINGH, ANOOP KUMAR | 1632 | §101§112 | Final Rejection | — | Pending | Dec 01, 2023 |
| 18526794 | METHODS FOR TARGETED INSERTION OF DNA IN GENES | SINGH, ANOOP KUMAR | 1632 | §101§112 | Final Rejection | — | Pending | Dec 01, 2023 |
| 18526826 | METHODS FOR TARGETED INSERTION OF DNA IN GENES | SINGH, ANOOP KUMAR | 1632 | §103§112 | Final Rejection | — | Pending | Dec 01, 2023 |
| 17802678 | METHODS FOR TREATING GAIN-OF-FUNCTION DISORDERS COMBINING GENE EDITING AND GENE THERAPY | TRAN, CHRISTINA L | 1637 | §103§112 | Non-Final OA | — | Pending | Aug 26, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBLUEALLELE CORPORATION has 5 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Anoop Kumar Singh has the most, with 3 of BLUEALLELE CORPORATION's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
